1. Home
  2. ENFY vs KPRX Comparison

ENFY vs KPRX Comparison

Compare ENFY & KPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENFY
  • KPRX
  • Stock Information
  • Founded
  • ENFY 1987
  • KPRX 1998
  • Country
  • ENFY China
  • KPRX United States
  • Employees
  • ENFY 424
  • KPRX N/A
  • Industry
  • ENFY
  • KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • ENFY
  • KPRX Health Care
  • Exchange
  • ENFY NYSE
  • KPRX Nasdaq
  • Market Cap
  • ENFY 11.8M
  • KPRX 10.0M
  • IPO Year
  • ENFY N/A
  • KPRX N/A
  • Fundamental
  • Price
  • ENFY $0.80
  • KPRX $3.91
  • Analyst Decision
  • ENFY
  • KPRX Strong Buy
  • Analyst Count
  • ENFY 0
  • KPRX 1
  • Target Price
  • ENFY N/A
  • KPRX $10.00
  • AVG Volume (30 Days)
  • ENFY 50.0K
  • KPRX 54.6K
  • Earning Date
  • ENFY 02-07-2025
  • KPRX 11-08-2024
  • Dividend Yield
  • ENFY N/A
  • KPRX N/A
  • EPS Growth
  • ENFY N/A
  • KPRX N/A
  • EPS
  • ENFY N/A
  • KPRX 1.69
  • Revenue
  • ENFY $90,812,865.00
  • KPRX $16,020,000.00
  • Revenue This Year
  • ENFY N/A
  • KPRX N/A
  • Revenue Next Year
  • ENFY N/A
  • KPRX N/A
  • P/E Ratio
  • ENFY N/A
  • KPRX $2.31
  • Revenue Growth
  • ENFY N/A
  • KPRX N/A
  • 52 Week Low
  • ENFY $0.75
  • KPRX $3.00
  • 52 Week High
  • ENFY $3.32
  • KPRX $8.98
  • Technical
  • Relative Strength Index (RSI)
  • ENFY N/A
  • KPRX 60.98
  • Support Level
  • ENFY N/A
  • KPRX $3.10
  • Resistance Level
  • ENFY N/A
  • KPRX $4.00
  • Average True Range (ATR)
  • ENFY 0.00
  • KPRX 0.25
  • MACD
  • ENFY 0.00
  • KPRX 0.02
  • Stochastic Oscillator
  • ENFY 0.00
  • KPRX 90.00

About ENFY ENLIGHTIFY INC

Enlightify Inc Formerly China Green Agriculture Inc is engaged in the business of fertilizer and agricultural products. It involves the research, development, production, distribution, and sale of humic acid-based compound fertilizers, blended fertilizers, organic compound fertilizers, slow-release fertilizers, concentrated water-soluble fertilizers, and mixed organic-inorganic compound fertilizers and the development, production, and distribution of agricultural products, such as top-grade fruits, vegetables, flowers and colored seedlings in China. The company operates in four segments: Jinong (fertilizer production), Gufeng (fertilizer production), Yuxing (agricultural products production), and Antaeus (Bitcoin). All of its operations are conducted in China.

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

Share on Social Networks: